A
A Ogunledun
Researcher at College of Health Sciences, Bahrain
Publications - 9
Citations - 307
A Ogunledun is an academic researcher from College of Health Sciences, Bahrain. The author has contributed to research in topics: Drug resistance & Shigella. The author has an hindex of 6, co-authored 9 publications receiving 274 citations.
Papers
More filters
Journal ArticleDOI
In Vitro Antimicrobial Properties of Aqueous Garlic Extract Against Multidrug-Resistant Bacteria and Candida Species from Nigeria
TL;DR: The antimicrobial effects of aqueous garlic extract (AGE) against 133 multidrug-resistant gram-positive and gram-negative bacterial isolates and five distinct time-kill profiles among the isolates tested support the use of garlic in health products and herbal remedies in Nigeria.
Journal ArticleDOI
Epidemiology of shigellosis in Lagos, Nigeria: trends in antimicrobial resistance.
Bamidele A. Iwalokun,G. O. Gbenle,Stella I. Smith,A Ogunledun,K. A. Akinsinde,E. A. Omonigbehin +5 more
TL;DR: The results of this study revealed the endemicity of shigellosis with S. flexneri as the predominant serogroup in Lagos and suggested that ampicillin, tetracycline, co-trimoxazole, and streptomycin should not be used as the first-line drugs in the treatment of shIGellosis.
Journal ArticleDOI
Levels and interactions of plasma xanthine oxidase, catalase and liver function parameters in Nigerian children with Plasmodium falciparum infection.
TL;DR: It is concluded that elevated levels of XO and liver enzymes are biochemical features of Plasmodium falciparum parasitaemia in Nigerian children, with both parameters interacting differently to modulate the catalase response in asymptomatic and symptomatic falcIParum malaria.
Journal Article
Antibiotic susceptibility patterns of Pseudomonas aeruginosa to available antipseudomonal drugs in Ibadan, Nigeria.
TL;DR: The Pseudomonas aeruginosa species harboured by in-pat patients showed higher rates of antibiotic resistance than those of the out-patients and amikacin and ciprofloxacin were the two antibiotics found to be most potent against this pathogen.
Journal ArticleDOI
Effects of gyrA and parC Mutations in Quinolones Resistant Clinical Gram Negative Bacteria from Nigeria
TL;DR: Quinolone resistance in clinical Gram negative bacteria in Nigeria is also mediated by accumulation of mutations at QRDR, as demonstrated by analysis of 115 isolates analyzed.